• GW4064 Workflows for FXR Metabolic Research

  2026-08-13

  GW4064 is a selective non-steroidal FXR agonist for connecting receptor activation with bile acid metabolism, cholesterol and triglyceride regulation, inflammation, and fibrotic phenotypes. This practical guide covers cell-based assay design, ferroptosis and FXR/TLR4 readouts, formulation controls, and troubleshooting for reproducible metabolic research.

• From Cas9 mRNA Design to Editing Precision

  2026-08-13

  Precision genome editing is shaped not only by guide design and nuclease fidelity, but also by how Cas9 mRNA is capped, modified, translated, exported, and cleared. This thought-leadership article connects the architecture of EZ Cap™ Cas9 mRNA (m1Ψ) with findings that link Cas9 mRNA nuclear export to editing control. It provides a translational framework for validating capped, modified Cas9 mRNA in mammalian cells while distinguishing product attributes from independently demonstrated performance.

• A40926 for Reliable Antibacterial Assays

  2026-08-12

  Learn how A40926 (SKU BA1486) can help laboratories design interpretable in vitro antibacterial, MRSA, and Neisseria gonorrhoeae inhibition studies. This scenario-based guide connects mechanism, concentration selection, endpoint control, and practical product evaluation to evidence-backed assay planning.

• HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus

  2026-08-11

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus supports in vitro transcription of randomly Cy3-modified RNA probes for fluorescence-based detection. It is intended for research workflows such as in situ hybridization and Northern blotting, not diagnostic, therapeutic, or medical use.

• A40926: From Cell-Wall Target to Assay Design

  2026-08-11

  A40926 is a dalbavancin precursor whose glycopeptide chemistry connects cell-wall inhibition with organism-specific assay design. This evidence-based guide explains how to interpret MIC data, distinguish A40926 factors, and build more reproducible antibacterial studies.

• Batimastat (BB-94): A Guide to Causal MMP Testing

  2026-08-10

  Batimastat (BB-94) is a broad-spectrum hydroxamate MMP inhibitor for dissecting proteolytic mechanisms in cancer and neuromuscular models. This guide focuses on assay logic, temporal control, and how to interpret MMP-dependent BDNF processing without confusing extracellular proteolysis with secretion or trafficking.

• Sulfamonomethoxine Toxicity Across Aquatic Species

  2026-08-09

  Huang and colleagues evaluated the acute and chronic toxicity of sulfamonomethoxine across algae, cladocerans, and medaka, addressing a major gap in aquatic risk information for this widely used veterinary sulfonamide. The study shows that microalgae were generally more sensitive than cladocerans and that chronic reproductive endpoints detected toxicity at lower concentrations than acute assays.

• Calpain Inhibitor I, ALLN: Technical Workflow

  2026-08-08

  Calpain Inhibitor I, ALLN (SKU A2602) provides a defined calpain I/II and cathepsin B/L inhibition profile for apoptosis, inflammation, and ischemia-reperfusion workflows. Use it to test protease involvement with matched vehicle controls and assay-specific readouts; do not treat dossier observations as a substitute for a validated dose, schedule, or clinical use.

• SmD2 Acetylation Links Splicing to PARP Sensitivity

  2026-08-07

  This Nature Communications study identifies SmD2 acetylation as a regulatory connection between core spliceosome function, BRCA1/FANC cassette-exon selection, and DNA-damage repair in hepatocellular carcinoma. Its data support combining HDAC2-directed pharmacology with PARP inhibition to expose a therapeutic vulnerability in HCC models.

• IWP-L6: Precision Porcupine Inhibitor for Wnt Modulation

  2026-08-07

  IWP-L6 enables ultra-potent, reproducible control of Wnt signaling through Porcupine inhibition, empowering researchers to dissect developmental, metabolic, and regenerative pathways with sub-nanomolar precision. This guide delivers actionable workflows, troubleshooting insights, and protocol enhancements for advanced Wnt pathway studies using IWP-L6.

• 5X Protein Loading Buffer (Reducing): Practical SDS-PAGE Use

  2026-08-06

  5X Protein Loading Buffer (Reducing) streamlines protein sample preparation for SDS-PAGE by ensuring consistent denaturation and reduction of disulfide bonds. It is appropriate for workflows that require accurate separation of proteins by molecular weight under reducing conditions, but should not be used in analyses where native protein structure or non-reducing conditions are necessary.

• E-4031 and hERG Blockade: Translational Impact in Cardiac Sa

  2026-08-06

  Explore the mechanistic, experimental, and strategic landscape of E-4031 as a selective hERG potassium channel blocker. This thought-leadership article guides translational researchers through the biological rationale, experimental protocols, and competitive context—revealing how E-4031, offered by APExBIO, underpins advances in proarrhythmic substrate modeling and cardiac safety assessment.

• QNZ (EVP4593): Transforming NF-κB Modulation in Translationa

  2026-08-05

  This article delivers a mechanistic and translational deep dive into QNZ (EVP4593), a potent quinazoline NF-κB inhibitor, highlighting its experimental precision, relevance for anti-inflammatory and neurodegenerative disease models, and providing actionable protocol guidance. It contextualizes QNZ’s impact against the competitive landscape and explores the strategic evolution of NF-κB modulation for future translational breakthroughs.

• Dihydrotestosterone (DHT): Applied Workflows and Troubleshoo

  2026-08-05

  Harness Dihydrotestosterone (DHT) for precise control of androgen receptor and EGFR signaling in cancer and neurodegeneration studies. This guide translates cutting-edge research—including synergistic protocol innovations—into actionable steps and troubleshooting strategies for robust experimental outcomes.

• Linezolid: Oxazolidinone Antimicrobial Workflows & Troublesh

  2026-08-04

  Linezolid, a synthetic oxazolidinone antimicrobial, enables precise inhibition of bacterial protein synthesis for resistance modeling, MRSA research, and translational workflows. This guide delivers stepwise protocols, performance insights, and troubleshooting strategies to optimize Linezolid use in applied settings.

450 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page